The top life sciences insights from 2021 run the gamut from cell and gene therapy to cybersecurity to the always topical data and analytics. As businesses in the life sciences industry continue to evolve with and through the pandemic, they’ve employed a wide array of strategies, tools, and technologies to meet the demands of our new landscape. Click here to read more life sciences insights and subscribe below to stay up to date.

The Impact of IOT Industry 4.0 to Pharmaceutical Operations

Prior to the onset of the COVID pandemic, life sciences businesses were already making steady investments in IOT Industry 4.0 technologies. As a result of the pandemic, many businesses have accelerated or reprioritized aspects of this strategic transformation. In this piece, Life Sciences Industry Lead and Partner Janel Firestein walks through the implications of adopting Industry 4.0 in pharmaceutical operations and how businesses should consider approaching this evolution.

Cell and Gene Therapy Test Environment Management

The transition to cell and gene therapy requires massive, thorough, and complex orchestration across not only your own business but partners, stakeholders, and constituents in the value chain of care. In part 1 of this series on program management in cell and gene therapy, Partner Janel Firestein covers the critically important aspects of test environment management.

Decentralized Clinical Trials Challenges and Obstacles

Decentralized clinical trials have rapidly accelerated in prevalence as a result of the pandemic. After decades of clinical trial operations that remained relatively unchanged, the switch to a decentralized model brings about a whole host of challenges. Challenges, however, that give way to an array of potential gains from a decentralized model including improved patient retention, enhanced data sets, improved patient engagement, and more. Clarkston Partners Brajinder Singh and Janel Firestein explore the key decentralized clinical trial challenges in this piece.

How to Protect Your Vaccine Supply Chain from Cyberattacks

Both vaccine supply chains and cybersecurity have been hot button issues in the life sciences industry over the last two years. With increased reliance on digital technologies, the threats that cybersecurity lapses pose on life sciences businesses are only growing every day. In this piece, Client Solutions Executive Lynette Nazabal details tips for businesses looking to shore up their vaccine supply chain security.

Evolving the Pharmaceutical Sales Model with Data Exchange

Long gone are the days of the traditional pharmaceutical sales model. In place of in-person visits and endless trade shows, many life sciences businesses are investing in the potential of big data to unlock greater potential from their sales force. In this piece, Data Consultant Mike Onore dives into how businesses can evolve their sales model with data exchange in order to improve both the efficiency and effectiveness of sales efforts.

A Life Sciences Marketing Maturity Model: How Do You Measure Up?

While businesses in consumer-facing industries have adopted digital marketing tactics for quite some time, the life sciences industry has only more recently begun adopting a digital model in marketing. In this piece by Clarkston Manager Anna Ivashko, Anna introduces a life sciences maturity model to help businesses understand how they benchmark against their peers in the industry.

Lessons Learned from over a Decade As An Organizational Change Management Consultant

It’s a cliché for a reason – change is really the only constant. For the life sciences industry, innovation and disruption have defined the past few years. Here, Change Management Expert and Clarkston Consultant Eileen George shares her experiences from over a decade of change management experience. Eileen’s insights are unmatched as she’s helped some of the industry’s most successful businesses pursue and achieve true change and transformation.